BridgeMD
New treatment option for Recurrent Inguinal Hernia
Official title TAPP and Open Repair for Recurrent Inguinal Hernia
ClinicalTrials.gov ID: NCT06604572
What this study is testing
- What it's testing
- The objective of this study was to explore the clinical efficacy of transabdominal preperitoneal approach (TAPP) and open tension-free hernia repair in the treatment of recurrent inguinal hernia. This study aims to provide a basis for selecting the optimal treatment methods for recurrent hernias.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- age ≥ 18 years
- the diagnosis of recurrent inguinal hernia made by ultrasound or computed tomography (CT) during the present visit
- ability to tolerate general anesthesia and local anesthesia surgery
- all patients and their families agreed to participate in this study and sign relevant informed consent.
You likely can't join if
- patch infection during the first surgery
- multiple (≥ 2) relapses
- inability to cooperate to complete follow-up after surgery
The study team makes the final eligibility decision.
Where it's taking place
- Kunming, Yunnan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kunming, Yunnan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.